Accepted for/Published in: JMIR Research Protocols
Date Submitted: May 13, 2026
Date Accepted: Oct 27, 2026
Comparative effects of mindful yoga and expressive arts on perceived stress and whole-person health in individuals with mild-to-moderate Parkinson’s disease: a randomized controlled trial protocol
ABSTRACT
Background:
People with Parkinson’s disease (PwPD) experience substantial motor, nonmotor, and psychosocial burdens that are often inadequately addressed by pharmacological treatments alone. Mind–body interventions (MBIs), including mindful yoga and expressive arts therapy (EXAT), have shown promise in alleviating stress and whole-person health. However, evidence of their comparative effectiveness and underlying mechanisms remains limited, leaving clinicians and patients with little guidance when selecting between these interventions. This study aims to fill this gap.
Objective:
The primary aim of this RCT is to evaluate and compare the effectiveness of mindful yoga and EXAT as adjunctive MBIs in reducing the perceived stress and improving the whole-person health of individuals with PD.
Methods:
We will conduct a two-arm, parallel-group, active-comparator randomized controlled trial. PwPDs will be randomly assigned to groups that will undergo mindful yoga or EXAT, which were delivered in six 90 min sessions performed every two weeks. The primary outcome will perceived stress. Secondary outcomes will encompass biological (gut microbiome), clinical, functional (constipation, motor and nonmotor symptoms, and physical activity), psychosocial (self-compassion, self-efficacy, and perceived social support), and health-related quality of life measures. Fecal samples will be collected to generate reproducible taxonomic and functional profiles of the gut microbiota. Outcomes will be assessed at baseline and 3, 6, and 9 months after baseline assessment. Comparative effectiveness will be explored using linear mixed models, and potential mechanisms, including interoceptive, psychosocial, and microbiome features, will be examined through path analysis. We hypothesize that both interventions will reduce stress and improve whole-person health but will have differential profiles of benefit.
Results:
The study was funded in March 2023, and data collection began in October 2023. As of May 2026, recruitment and follow-up are ongoing, with data collection expected to be completed in January 2027 for the last cohort’s 1-year follow-up. Data analysis has not yet started. Study findings are expected to be available and submitted for publication in March 2027.
Conclusions:
By directly comparing two active MBIs and integrating clinical, psychosocial, and metagenomic data, this trial will provide crucial evidence of the effectiveness of MBIs. The findings are intended to guide the selection of mind–body approaches in PD, supporting preference-sensitive, whole-person care and informing integrative models that address the complex needs of this population. Clinical Trial: ClinicalTrials.gov ID: NCT06078046
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.